Codeprex Pennkinetic
NDC Package 53014-826-67
Package Information
Codeprex Pennkinetic is a . Marketed by Ucb Manufacturing Inc, this product is identified by NDC 53014-826 and is authorized under FDA application NDA021369.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53014 - Ucb Manufacturing Inc
- 53014-826 - Codeprex Pennkinetic
- 53014-826-67 - 473 mL in 1 BOTTLE, PLASTIC
- 53014-826 - Codeprex Pennkinetic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53014-826-67 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Codeprex Pennkinetic, labeled by Ucb Manufacturing Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ucb Manufacturing Inc on June 21, 2004. The current certification is valid through June 22, 2004.
How is this Ucb Manufacturing Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53014082667. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.